RESEARCH PHARMACEUTICAL SERVICES, INC. (CIK: 0001420070) EDGAR, Information, Filings... CompaniesBIO.Com

RESEARCH PHARMACEUTICAL SERVICES, INC.

Mailing address
520 VIRGINIA DRIVE, FORT WASHINGTON, Delaware, 19034
Phone
215-540-0700
State location
Pennsylvania
State of incorporation
Delaware
Fiscal year end
December 31
SIC
8731 - (CF Office: Office of Trade & Services) SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Filings
N/A

RESEARCH PHARMACEUTICAL SERVICES, INC. (CIK: 0001420070) is an American company incorporated in the state of Pennsylvania. Head office is located at 520 VIRGINIA DRIVE, FORT WASHINGTON, Pennsylvania, 19034. Work in the industry 8731 - (CF Office: Office of Trade & Services) SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH. RESEARCH PHARMACEUTICAL SERVICES, INC. is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
COURNOT ANTOINE	0001454421	Dec-23-2008	officer: Pres. ? European Operations
MYERS WARREN W	0001434951	May-12-2008	director
ARMSTRONG THOMAS R	0001434952	May-12-2008	10 percent owner
DEAN JACK H	0001434978	May-12-2008	director
RAYNOR DANIEL	0001068854	Feb-12-2008	director, 10 percent owner
MACDONALD JAMES R	0001105185	Feb-12-2008	director, 10 percent owner
First Analysis Corp.	0001329700	Feb-12-2008	10 percent owner
Shah Samir	0001426831	Feb-12-2008	officer: Vice-President Strategic Dev.
Stonefield Stephen E	0001426833	Feb-12-2008	director
Koffer Harris	0001426835	Feb-12-2008	director, officer: President,COO and Director
Perlman Daniel M	0001426837	Feb-12-2008	director, officer: Chairman of the Board & CEO
Brennan Janet L	0001426839	Feb-12-2008	director
Arcangelo Joseph D	0001426842	Feb-12-2008	officer: EVP Recruitment Operations
Bell Steven	0001426847	Feb-12-2008	officer: EVP Finance, CFO
Yu Peter	0001426890	Feb-12-2008	10 percent owner
Argentum Investments, LLC	0001427715	Feb-12-2008	other: See footnotes
Argentum Partners II, LLC	0001427716	Feb-12-2008	other: See footnotes
Argentum Capital Partners II, L.P.	0001427717	Feb-12-2008	10 percent owner
Pangaea One Acquisition Holding I, LLC	0001429245	Feb-12-2008	10 percent owner

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by RESEARCH PHARMACEUTICAL SERVICES, INC.

Filings	Format	Description	Filed/Effective	File/Film Number
424B5	Document	Prospectus filed pursuant to Rule 424(b)(5) Acc-no: 0001140361-24-023855 (33 Act) Size: 1624 KB	May-02-2024	333-278943-06 24906012
424B5	Document	Prospectus filed pursuant to Rule 424(b)(5) Acc-no: 0001140361-24-022283 (33 Act) Size: 1585 KB	Apr-26-2024	333-278943-06 24879243
F-3ASR	Document	Automatic shelf registration statement of securities of well-known seasoned issuers Acc-no: 0001140361-24-022268 (33 Act) Size: 2153 KB	Apr-26-2024	333-278943-06 24878935
RW	Document	Registration Withdrawal Request Acc-no: 0000950123-11-087207 (NE Act) Size: 45 KB	Sep-28-2011	333-167617 111110969
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0000950123-11-015784 (34 Act) Size: 10 KB	Feb-18-2011	000-52981 11625464
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0000950123-11-015762 (33 Act) Size: 23 KB	Feb-18-2011	333-151436 11625310
DEFM14C	Document	Definitive information statement relating to merger or acquisition Acc-no: 0000950123-11-004916 (34 Act) Size: 979 KB	Jan-25-2011	000-52981 11544604
PREM14C	Document	Preliminary information statements relating to merger or acquisition Acc-no: 0000950123-11-003082 (34 Act) Size: 790 KB	Jan-14-2011	000-52981 11531189
8-K	Document	Current report filing Acc-no: 0000950123-10-116662 (34 Act) Size: 396 KB	Dec-28-2010	000-52981 101275525
S-1/A	Document	Amendment to General form of registration statement for all companies including face-amount certificate companies Acc-no: 0000950123-10-108217 (33 Act) Size: 2624 KB	Nov-23-2010	333-167617 101211700
8-K	Document	Current report filing Acc-no: 0000950123-10-101565 (34 Act) Size: 71 KB	Nov-05-2010	000-52981 101168005
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950123-10-101562 (34 Act) Size: 315 KB	Nov-05-2010	000-52981 101167998
8-K	Document	Current report filing Acc-no: 0000950123-10-099176 (34 Act) Size: 54 KB	Nov-02-2010	000-52981 101156721
S-1/A	Document	Amendment to General form of registration statement for all companies including face-amount certificate companies Acc-no: 0000950123-10-090808 (33 Act) Size: 2655 KB	Oct-01-2010	333-167617 101102509
8-K	Document	Current report filing Acc-no: 0000950123-10-077268 (34 Act) Size: 73 KB	Aug-13-2010	000-52981 101015121
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-10-041913 ( Act) Size: 7 KB	Aug-10-2010
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950123-10-074093 (34 Act) Size: 313 KB	Aug-06-2010	000-52981 10997516
8-K	Document	Current report filing Acc-no: 0000950123-10-074090 (34 Act) Size: 76 KB	Aug-06-2010	000-52981 10997509
S-1	Document	General form of registration statement for all companies including face-amount certificate companies Acc-no: 0000950123-10-059302 (33 Act) Size: 6453 KB	Jun-18-2010	333-167617 10905839
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-10-034149 ( Act) Size: 5 KB	Jun-15-2010

Recent 20 filings. View all RESEARCH PHARMACEUTICAL SERVICES, INC. filings

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

RESEARCH PHARMACEUTICAL SERVICES, INC. overview
RESEARCH PHARMACEUTICAL SERVICES, INC. job
RESEARCH PHARMACEUTICAL SERVICES, INC. stock
RESEARCH PHARMACEUTICAL SERVICES, INC. ownership
RESEARCH PHARMACEUTICAL SERVICES, INC. CEO
RESEARCH PHARMACEUTICAL SERVICES, INC. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.